News & Updates
Filter by Specialty:
Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
In the treatment of patients with chronic hepatitis B (CHB), the novel tenofovir amibufenamide (TMF) is as good as tenofovir disoproxil fumarate (TDF) in terms of efficacy but with the advantage of better bone and renal safety, according to the results of a noninferiority trial.
Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
08 Nov 2021
Nerve block may provide relief for pancreatic cancer pain
Neurolytic splanchnic nerve block (SNB) appears effective for pain control in patients with moderate-to-severe pain due to unresectable pancreatic cancer, a study has shown.
Nerve block may provide relief for pancreatic cancer pain
04 Nov 2021
Transplantation bias, misconceptions endure for alcohol-, obesity-related liver disease
Bias and misconceptions about liver transplantation persist for patients with alcohol- (ALD) and obesity-related liver disease (OLD), a study has found.
Transplantation bias, misconceptions endure for alcohol-, obesity-related liver disease
02 Nov 2021
Antigliadin IgG spots IBS patients who benefit from gluten-free diet
Some patients with irritable bowel syndrome (IBS) may achieve symptom reduction, particularly diarrhoea, on a gluten-free diet, and who these patients are may be identified by using the antigliadin immunoglobulin G (IgG) as a biomarker, according to a study.
Antigliadin IgG spots IBS patients who benefit from gluten-free diet
02 Nov 2021
Sustained benefit with anti-TNFα less likely to lead to subsequent loss of response in IBD
Inflammatory bowel disease (IBD) patients receiving treatment with antitumour necrosis factor alpha (anti-TNFα) for more than 2 years represent a distinct group who obtain prolonged clinical benefit and tolerate maintenance treatment, according to a study.